首页 > 最新文献

Acta Hepatologica Japonica最新文献

英文 中文
An autopsy case of brown atrophy of the liver with pancreatic cancer 胰腺癌症并发肝褐色萎缩的尸检报告
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.2957/kanzo.64.12
Shoko Suzuki, T. Hosokawa, K. Uraushihara, Atsushi Kawaguchi, Y. Sakurai, Masayuki Kobayashi, Kazumasa Ohno, Ohki Kikuchi, Yuichi Takeda, T. Yoshimoto
{"title":"An autopsy case of brown atrophy of the liver with pancreatic cancer","authors":"Shoko Suzuki, T. Hosokawa, K. Uraushihara, Atsushi Kawaguchi, Y. Sakurai, Masayuki Kobayashi, Kazumasa Ohno, Ohki Kikuchi, Yuichi Takeda, T. Yoshimoto","doi":"10.2957/kanzo.64.12","DOIUrl":"https://doi.org/10.2957/kanzo.64.12","url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45723045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current understanding of liver resection in the treatment of hepatocellular carcinoma 肝切除术治疗肝细胞癌的认识现状
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.2957/kanzo.64.1
T. Kurihara, S. Itoh, M. Hidaka, S. Eguchi, T. Yoshizumi
{"title":"Current understanding of liver resection in the treatment of hepatocellular carcinoma","authors":"T. Kurihara, S. Itoh, M. Hidaka, S. Eguchi, T. Yoshizumi","doi":"10.2957/kanzo.64.1","DOIUrl":"https://doi.org/10.2957/kanzo.64.1","url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44360419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report of pure laparoscopic hepatectomy for Fontan procedure-related liver cancer: From the viewpoint of liver parenchymal dissection in Fontan circulation 纯腹腔镜肝切除术治疗Fontan手术相关肝癌1例:从Fontan循环肝实质剥离的角度分析
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.2957/kanzo.64.18
Yu Saito, Y. Morine, S. Yamada, H. Teraoku, T. Ikemoto, M. Shimada
{"title":"A case report of pure laparoscopic hepatectomy for Fontan procedure-related liver cancer: From the viewpoint of liver parenchymal dissection in Fontan circulation","authors":"Yu Saito, Y. Morine, S. Yamada, H. Teraoku, T. Ikemoto, M. Shimada","doi":"10.2957/kanzo.64.18","DOIUrl":"https://doi.org/10.2957/kanzo.64.18","url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42296596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of diet and exercise program for fatty liver-Trial of "Hospitalization program for improvement purpose for the fatty liver" 饮食和运动计划对脂肪肝的有效性——“以改善脂肪肝为目的的住院治疗计划”的试验
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.2957/kanzo.64.26
N. Akuta, Shunichiro Fujiyama, Y. Kawamura, S. Saitoh, H. Sezaki, T. Hosaka, M. Kobayashi, Y. Arase, K. Ikeda, H. Kumada, Yoshiyuki Suzuki, F. Suzuki
{"title":"Usefulness of diet and exercise program for fatty liver-Trial of \"Hospitalization program for improvement purpose for the fatty liver\"","authors":"N. Akuta, Shunichiro Fujiyama, Y. Kawamura, S. Saitoh, H. Sezaki, T. Hosaka, M. Kobayashi, Y. Arase, K. Ikeda, H. Kumada, Yoshiyuki Suzuki, F. Suzuki","doi":"10.2957/kanzo.64.26","DOIUrl":"https://doi.org/10.2957/kanzo.64.26","url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42412617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Status of 18 pediatric cases of COVID-19 post-liver transplantation 18例小儿肝移植术后新冠肺炎病例分析
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.2957/kanzo.63.538
Y. Hirata, Y. Sanada, Y. Onishi, N. Okada, T. Horiuchi, Y. Sakuma
We describe our experience with COVID-19 after pediatric liver transplantation (LT). In this study, we analyzed 18 of 196 children who contracted COVID-19 after LT during outpatient follow-up at our department. The severity of COVID-19 was mild in all cases, and all cases were cured without sequelae. COVID-19 after LT in children may have a high risk of severe disease. However, the disease is relatively mild and may be cured. Copyright © 2022 The Japan Society of Hepatology.
我们描述了我们在小儿肝移植(LT)后感染COVID-19的经验。在本研究中,我们分析了196名在我科门诊随访期间LT后感染COVID-19的儿童中的18名。所有病例病情轻微,全部治愈,无后遗症。儿童LT后感染COVID-19可能有很高的严重疾病风险。然而,这种病相对较轻,是可以治愈的。版权所有©2022日本肝病学会。
{"title":"Status of 18 pediatric cases of COVID-19 post-liver transplantation","authors":"Y. Hirata, Y. Sanada, Y. Onishi, N. Okada, T. Horiuchi, Y. Sakuma","doi":"10.2957/kanzo.63.538","DOIUrl":"https://doi.org/10.2957/kanzo.63.538","url":null,"abstract":"We describe our experience with COVID-19 after pediatric liver transplantation (LT). In this study, we analyzed 18 of 196 children who contracted COVID-19 after LT during outpatient follow-up at our department. The severity of COVID-19 was mild in all cases, and all cases were cured without sequelae. COVID-19 after LT in children may have a high risk of severe disease. However, the disease is relatively mild and may be cured. Copyright © 2022 The Japan Society of Hepatology.","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42199160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of possible drug-induced liver injury due to COVID-19 vaccine 新冠肺炎疫苗可能致药物性肝损伤1例
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.2957/kanzo.63.530
Soichiro Shimizu, Ken Sato, K. Ito, Aoi Kita, Kousuke Aihara, Y. Tateyama, T. Abe, M. Shibasaki, Setsuo Yamazaki, Y. Fukai, K. Iizuka, D. Takizawa, H. Arai, M. Ide, T. Uraoka
The patient presented with nausea, appetite loss, and fatigue. She had received two doses of Pfizer/BioN-Tech BNT162b2 mRNA vaccine (COMIRNATYR) for coronavirus disease 2019 (COVID-19). Acute liver injury was noted 14 days after the first dose of the vaccine. Re-exposure through the second dose worsened the liver injury. After liver biopsy on the third day of admission, methylprednisolone (1000 mg) was administered. Liver histology showed acute hepatitis with diffuse lobular inflammation/necrosis and lymphocyte-dominant infiltra-tion in the portal areas. The patient was diagnosed with drug-induced liver injury due to the COVID-19 vaccine based on the Digestive Disease Week Japan 2004 (DDW-J) scale, which assesses the temporal relationship, liver biopsy, and laboratory findings. With improvements in the blood test parameters, prednisolone was gradually tapered and stopped. One month later, no biochemical signs of relapse were noted. To our knowledge, this is the first report describing liver injury after the administration of the Pfizer COVID-19 vaccine in Japan. Copyright © 2022 The Japan Society of Hepatology.
病人表现为恶心、食欲不振和疲劳。她接受了两剂辉瑞/BioN-Tech 2019冠状病毒病(COVID-19) BNT162b2 mRNA疫苗(COMIRNATYR)。第一剂疫苗接种后14天出现急性肝损伤。第二剂量的再次暴露加重了肝损伤。入院第3天肝活检后,给予甲基强的松龙(1000 mg)。肝脏组织学显示急性肝炎伴弥漫性小叶炎症/坏死,门静脉区以淋巴细胞为主浸润。根据日本消化疾病周刊2004 (DDW-J)量表,评估时间关系、肝活检和实验室检查结果,诊断患者为COVID-19疫苗引起的药物性肝损伤。随着血液检查参数的改善,泼尼松龙逐渐逐渐减少并停止使用。一个月后,没有发现复发的生化迹象。据我们所知,这是日本首次出现辉瑞新冠疫苗接种后肝损伤的报告。版权所有©2022日本肝病学会。
{"title":"A case of possible drug-induced liver injury due to COVID-19 vaccine","authors":"Soichiro Shimizu, Ken Sato, K. Ito, Aoi Kita, Kousuke Aihara, Y. Tateyama, T. Abe, M. Shibasaki, Setsuo Yamazaki, Y. Fukai, K. Iizuka, D. Takizawa, H. Arai, M. Ide, T. Uraoka","doi":"10.2957/kanzo.63.530","DOIUrl":"https://doi.org/10.2957/kanzo.63.530","url":null,"abstract":"The patient presented with nausea, appetite loss, and fatigue. She had received two doses of Pfizer/BioN-Tech BNT162b2 mRNA vaccine (COMIRNATYR) for coronavirus disease 2019 (COVID-19). Acute liver injury was noted 14 days after the first dose of the vaccine. Re-exposure through the second dose worsened the liver injury. After liver biopsy on the third day of admission, methylprednisolone (1000 mg) was administered. Liver histology showed acute hepatitis with diffuse lobular inflammation/necrosis and lymphocyte-dominant infiltra-tion in the portal areas. The patient was diagnosed with drug-induced liver injury due to the COVID-19 vaccine based on the Digestive Disease Week Japan 2004 (DDW-J) scale, which assesses the temporal relationship, liver biopsy, and laboratory findings. With improvements in the blood test parameters, prednisolone was gradually tapered and stopped. One month later, no biochemical signs of relapse were noted. To our knowledge, this is the first report describing liver injury after the administration of the Pfizer COVID-19 vaccine in Japan. Copyright © 2022 The Japan Society of Hepatology.","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47688177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The great results of our unique intrahospital cooperation alert system for positive hepatitis C test results 我们独特的丙型肝炎检测阳性医院内部合作警报系统取得了巨大成果
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.2957/kanzo.63.522
Yusuke Kito, T. Mizushima, Kenji Urakabe, R. Ishihara, A. Minowa, Yuta Suzuki, K. Haneda, Hironobu Tsukamoto, Fumihiro Okumura
{"title":"The great results of our unique intrahospital cooperation alert system for positive hepatitis C test results","authors":"Yusuke Kito, T. Mizushima, Kenji Urakabe, R. Ishihara, A. Minowa, Yuta Suzuki, K. Haneda, Hironobu Tsukamoto, Fumihiro Okumura","doi":"10.2957/kanzo.63.522","DOIUrl":"https://doi.org/10.2957/kanzo.63.522","url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46454863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JSH Guidelines for Management of Hepatitis B Virus Infection, and JSH Guidelines for Management of Hepatitis C Virus Infection: 2022 update JSH乙肝病毒感染管理指南和JSH丙型肝炎病毒感染管理指导方针:2022年更新
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.2957/kanzo.63.509
G. Suda, A. Tanaka
{"title":"JSH Guidelines for Management of Hepatitis B Virus Infection, and JSH Guidelines for Management of Hepatitis C Virus Infection: 2022 update","authors":"G. Suda, A. Tanaka","doi":"10.2957/kanzo.63.509","DOIUrl":"https://doi.org/10.2957/kanzo.63.509","url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49565889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of autoimmune hepatitis following administration of the COVID19 vaccine 接种covid - 19疫苗后发生自身免疫性肝炎1例
Q4 Medicine Pub Date : 2022-11-01 DOI: 10.2957/kanzo.63.491
Sen Yagi, Junichirou Tamai, Takao Watanabe, Makoto Yoshida, Yoshio Tokumoto, Masanori Abe, Kazuki Murakami, Makoto Satou, Kazuki Niida, Yuuya Miyamoto, Fumi Umeoka, Hidehiro Murakami, Shunji Okita, H. Miyaoka, T. Okada, Youichi Hiasa
{"title":"A case of autoimmune hepatitis following administration of the COVID19 vaccine","authors":"Sen Yagi, Junichirou Tamai, Takao Watanabe, Makoto Yoshida, Yoshio Tokumoto, Masanori Abe, Kazuki Murakami, Makoto Satou, Kazuki Niida, Yuuya Miyamoto, Fumi Umeoka, Hidehiro Murakami, Shunji Okita, H. Miyaoka, T. Okada, Youichi Hiasa","doi":"10.2957/kanzo.63.491","DOIUrl":"https://doi.org/10.2957/kanzo.63.491","url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46187680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of alcohol-related liver cirrhosis diagnosed with thrombotic microangiopathy by renal biopsy 酒精相关性肝硬化经肾活检诊断为血栓性微血管病变1例
Q4 Medicine Pub Date : 2022-11-01 DOI: 10.2957/kanzo.63.473
Yoshiko Nakamura, Yoshio Tokumoto, Ryou Yano, Kotarou Sunago, Atsushi Yukimoto, Takaaki Tanaka, Takao Watanabe, Y. Koizumi, O. Yoshida, M. Hirooka, E. Takeshita, M. Abe, K. Miyoshi, B. Matsuura, Y. Hiasa
{"title":"A case of alcohol-related liver cirrhosis diagnosed with thrombotic microangiopathy by renal biopsy","authors":"Yoshiko Nakamura, Yoshio Tokumoto, Ryou Yano, Kotarou Sunago, Atsushi Yukimoto, Takaaki Tanaka, Takao Watanabe, Y. Koizumi, O. Yoshida, M. Hirooka, E. Takeshita, M. Abe, K. Miyoshi, B. Matsuura, Y. Hiasa","doi":"10.2957/kanzo.63.473","DOIUrl":"https://doi.org/10.2957/kanzo.63.473","url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46029323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Hepatologica Japonica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1